Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan.

Literature DB >> 21479980

Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan.

Katsuhiro Miura^1,2, Hirotaka Takasaki³, Hideki Tsujimura³, Masatoshi Kanno³, Yoshinobu Maeda³, Naoto Tomita³, Kazue Takai³, Yasufumi Masaki³, Jun Takizawa³, Hiraku Mori³, Yasushi Terasaki³, Takashi Yoshida³, Jin Takeuchi^4,3, Shigeki Motomura³.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21479980 DOI： 10.1007/s12185-011-0845-4

Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490

× No keyword cloud information.

10 in total

Review 1. Current treatment strategy and new agents in mantle cell lymphoma.

Authors: Michinori Ogura
Journal: Int J Hematol Date: 2010-06-08 Impact factor: 2.490

2. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma.

Authors: N Ketterer; G Salles; D Espinouse; C Dumontet; E M Neidhardt-Berard; I Moullet; F Bouafia; F Berger; P Felman; B Coiffier
Journal: Ann Oncol Date: 1997-07 Impact factor: 32.976

3. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

Authors: Jorge E Romaguera; Luis Fayad; Maria A Rodriguez; Kristine R Broglio; Frederick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth L Katz; Harish Gagneja; Barry I Samuels; Terry L Smith; Fernando F Cabanillas
Journal: J Clin Oncol Date: 2005-09-06 Impact factor: 44.544

4. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).

Authors: Georg Lenz; Martin Dreyling; Eva Hoster; Bernhard Wörmann; Ulrich Dührsen; Bernd Metzner; Hartmut Eimermacher; Andreas Neubauer; Hannes Wandt; Hjalmar Steinhauer; Sonja Martin; Else Heidemann; Ali Aldaoud; Reza Parwaresch; Joerg Hasford; Michael Unterhalt; Wolfgang Hiddemann
Journal: J Clin Oncol Date: 2005-01-24 Impact factor: 44.544

5. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).

Authors: Alessandro M Gianni; Michele Magni; Maurizio Martelli; Massimo Di Nicola; Carmelo Carlo-Stella; Silvana Pilotti; Alessandro Rambaldi; Sergio Cortelazzo; Caterina Patti; Guido Parvis; Fabio Benedetti; Saveria Capria; Paolo Corradini; Corrado Tarella; Tiziano Barbui
Journal: Blood Date: 2003-03-27 Impact factor: 22.113

6. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.

Authors: A S Freedman; D Neuberg; J G Gribben; P Mauch; R J Soiffer; D C Fisher; K C Anderson; N Andersen; R Schlossman; M Kroon; J Ritz; J Aster; L M Nadler
Journal: J Clin Oncol Date: 1998-01 Impact factor: 44.544

7. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.

Authors: Christian H Geisler; Arne Kolstad; Anna Laurell; Niels S Andersen; Lone B Pedersen; Mats Jerkeman; Mikael Eriksson; Marie Nordström; Eva Kimby; Anne Marie Boesen; Outi Kuittinen; Grete F Lauritzsen; Herman Nilsson-Ehle; Elisabeth Ralfkiaer; Måns Akerman; Mats Ehinger; Christer Sundström; Ruth Langholm; Jan Delabie; Marja-Liisa Karjalainen-Lindsberg; Peter Brown; Erkki Elonen
Journal: Blood Date: 2008-07-14 Impact factor: 22.113

8. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.

Authors: Eva Hoster; Martin Dreyling; Wolfram Klapper; Christian Gisselbrecht; Achiel van Hoof; Hanneke C Kluin-Nelemans; Michael Pfreundschuh; Marcel Reiser; Bernd Metzner; Hermann Einsele; Norma Peter; Wolfram Jung; Bernhard Wörmann; Wolf-Dieter Ludwig; Ulrich Dührsen; Hartmut Eimermacher; Hannes Wandt; Joerg Hasford; Wolfgang Hiddemann; Michael Unterhalt
Journal: Blood Date: 2007-10-25 Impact factor: 22.113

9. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study.

Authors: R I Fisher; S Dahlberg; B N Nathwani; P M Banks; T P Miller; T M Grogan
Journal: Blood Date: 1995-02-15 Impact factor: 22.113

10. Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

Authors: Lloyd E Damon; Jeffrey L Johnson; Donna Niedzwiecki; Bruce D Cheson; David D Hurd; Nancy L Bartlett; Ann S Lacasce; Kristie A Blum; John C Byrd; Michael Kelly; Wendy Stock; Charles A Linker; George P Canellos
Journal: J Clin Oncol Date: 2009-11-16 Impact factor: 44.544